☆ 4.7 Article

Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease

FRONTIERS IN ENDOCRINOLOGY (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Gastroenterology & Hepatology

Waist Circumference and Insulin Resistance Are the Most Predictive Metabolic Factors for Steatosis and Fibrosis

Kajal Claypool et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella et al.

Summary: This study aimed to determine if there was a need to change the nomenclature and definition of NAFLD and NASH. Through a Delphi process involving content experts and patient advocates, a consensus was reached to replace NAFLD with metabolic dysfunction-associated steatotic liver disease (MetALD) and modify the diagnostic criteria. The new nomenclature and criteria are widely supported, nonstigmatizing, and can improve awareness and patient identification.

HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

What’s in a name? New nomenclature for steatotic liver disease - to be or not to be?

Georg Semmler et al.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis

Mads Israelsen et al.

Summary: This study found that insulin resistance is the strongest predictor of the severity of alcohol-related liver disease. Genetic susceptibility further aggravates this risk.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis

Livnat Alon et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of myocardial infarction (MI), ischaemic stroke (IS), atrial fibrillation (AF), and heart failure (HF). Age, sex, and study characteristics may moderate the strength of this association.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease

Panu K. Luukkonen et al.

Summary: This study demonstrated that the mechanisms underlying the metabolic and genetic components of NAFLD are fundamentally different. The metabolic component is characterized by hepatic oversupply of substrates, while the genetic component is characterized by impaired hepatic mitochondrial function.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study

Tiange Wang et al.

Summary: This study aimed to investigate the interaction between insulin resistance and cardiovascular disease (CVD) risk in different glucose tolerance statuses. Using data from the China Cardiometabolic Disease and Cancer Cohort Study, the researchers found that glucose intolerance exacerbates the association between insulin resistance and CVD risk. Both insulin resistance and obesity in individuals with prediabetes were associated with higher risks of CVD, while insulin resistance remained a risk factor for CVD in individuals with diabetes, regardless of obesity status.

DIABETES CARE (2022)

Add to Collection

Article Endocrinology & Metabolism

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality

Georg Semmler et al.

Summary: The presence of MAFLD does not increase mortality in individuals aged 45 to 80 years. However, lean and overweight patients with MAFLD had worse prognosis compared to their non-MAFLD counterparts, driven primarily by age and metabolic comorbidities.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Article Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study

Georg Semmler et al.

Summary: Lean patients with NAFLD have a higher prevalence of metabolic syndrome and increased cardiovascular risk. The novel criteria for metabolic associated fatty liver disease leave a considerable proportion of patients unclassified.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

Steven Hageman et al.

Summary: The study aimed to develop, validate, and demonstrate an updated prediction model (SCORE2) to estimate 10-year cardiovascular disease risk in individuals without previous history of CVD or diabetes in Europe. The new algorithm, SCORE2, enhances the identification of individuals at higher risk of developing CVD across Europe by predicting first-onset CVD risk in European populations.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population

Stefano Ciardullo et al.

Summary: In this population-based study, there was no independent association found between steatosis and fibrosis and cardiovascular disease. Further large prospective cohort studies are needed to provide more definitive evidence on this topic.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis

Alessandro Mantovani et al.

Summary: Studies have shown a significant association between non-alcoholic fatty liver disease (NAFLD) and increased risk of cardiovascular disease (CVD) incidence. The risk of fatal or non-fatal CVD events is moderately increased with NAFLD, and this risk escalates with the severity of NAFLD, particularly with higher fibrosis stages. These findings suggest that NAFLD may be an independent risk factor for CVD morbidity and mortality.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality

Georg Semmler et al.

Summary: In this single-center cohort study, the presence of MAFLD was not found to increase mortality among individuals aged 45 to 80. Factors such as body mass index (BMI) and metabolic comorbidities, particularly diabetes, were found to have a stronger impact on mortality rates.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Review Endocrinology & Metabolism

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

Robert Ross et al.

NATURE REVIEWS ENDOCRINOLOGY (2020)

Add to Collection

Letter Gastroenterology & Hepatology

Reply to: correspondence regarding A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement Bringing evidence to the NAFLD-MAFLD debate

Mohammed Eslam et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease

Georg Semmler et al.

PLOS ONE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Sex Differences in the Association Between Measures of General and Central Adiposity and the Risk of Myocardial Infarction: Results From the UK Biobank

Sanne A. E. Peters et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

Add to Collection

Review Immunology

Hyperferritinemia and inflammation

Kate F. Kernan et al.

INTERNATIONAL IMMUNOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Giulio Marchesini et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

Giovanni Targher et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Review Cell Biology

Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis

Akifumi Kushiyama et al.

MEDIATORS OF INFLAMMATION (2016)

Add to Collection

Article Multidisciplinary Sciences

Insulin Resistance and Risk of Incident Cardiovascular Events in Adults without Diabetes: Meta-Analysis

Karin B. Gast et al.

PLOS ONE (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

K. G. M. M. Alberti et al.

CIRCULATION (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.